全文获取类型
收费全文 | 179606篇 |
免费 | 11594篇 |
国内免费 | 709篇 |
专业分类
耳鼻咽喉 | 2511篇 |
儿科学 | 4919篇 |
妇产科学 | 3446篇 |
基础医学 | 23276篇 |
口腔科学 | 3551篇 |
临床医学 | 17625篇 |
内科学 | 38590篇 |
皮肤病学 | 2803篇 |
神经病学 | 17979篇 |
特种医学 | 6219篇 |
外国民族医学 | 13篇 |
外科学 | 26585篇 |
综合类 | 2319篇 |
现状与发展 | 3篇 |
一般理论 | 203篇 |
预防医学 | 13395篇 |
眼科学 | 4789篇 |
药学 | 11574篇 |
中国医学 | 203篇 |
肿瘤学 | 11906篇 |
出版年
2023年 | 698篇 |
2022年 | 1224篇 |
2021年 | 2871篇 |
2020年 | 1765篇 |
2019年 | 2905篇 |
2018年 | 3409篇 |
2017年 | 2457篇 |
2016年 | 2870篇 |
2015年 | 3460篇 |
2014年 | 5126篇 |
2013年 | 7909篇 |
2012年 | 11418篇 |
2011年 | 12277篇 |
2010年 | 6857篇 |
2009年 | 6326篇 |
2008年 | 11570篇 |
2007年 | 12356篇 |
2006年 | 11843篇 |
2005年 | 12191篇 |
2004年 | 11580篇 |
2003年 | 11057篇 |
2002年 | 10660篇 |
2001年 | 1514篇 |
2000年 | 1157篇 |
1999年 | 1628篇 |
1998年 | 2344篇 |
1997年 | 2026篇 |
1996年 | 1720篇 |
1995年 | 1591篇 |
1994年 | 1434篇 |
1993年 | 1362篇 |
1992年 | 1066篇 |
1991年 | 978篇 |
1990年 | 869篇 |
1989年 | 835篇 |
1988年 | 857篇 |
1987年 | 726篇 |
1986年 | 849篇 |
1985年 | 928篇 |
1984年 | 1242篇 |
1983年 | 1180篇 |
1982年 | 1645篇 |
1981年 | 1517篇 |
1980年 | 1419篇 |
1979年 | 791篇 |
1978年 | 912篇 |
1977年 | 802篇 |
1976年 | 710篇 |
1975年 | 570篇 |
1974年 | 596篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
Robert H. EckelAuthor Vitae Penny Kris-EthertonAuthor Vitae Alice H. LichtensteinAuthor Vitae Judith Wylie-RosettAuthor Vitae Allison Groom Author Vitae Kimberly F. StitzelAuthor Vitae Shirley Yin-PiazzaAuthor Vitae 《Journal of the American Dietetic Association》2009,109(2):288-296
In recent years, epidemiologic and clinical studies, public and regulatory policy activity, and media coverage have focused on issues related to trans fats. To help increase awareness and understanding of trans fats and other fats, the American Heart Association (AHA) launched the “Face the Fats” national consumer education campaign in April 2007. The AHA commissioned a quantitative tracking survey between 2006 and 2007 to measure changes in consumer awareness, knowledge, and behaviors related fats and oils and their perceived impact on heart disease. The survey was conducted by Cogent Research. Data were collected during March 2006 and May 2007. At both time points, the survey included a representative sample of the American population age 18 to 65 years (n=1,000). The sampling plan for the survey was designed based on the 2000 and 2003 US Census. The margin of error was ±3.10 percentage points. Awareness of trans fats increased during the 1-year study period. In 2007, 92% of respondents were aware of trans fats, an increase from 84% in 2006 (P<0.05). The 2007 level was similar to the awareness of saturated fats (93%). Perceptions that certain fats and oils heighten the risk of heart disease increased for trans fats (73% in 2007 vs 63% in 2006; P<0.05), saturated fats (77% in 2007 vs 73% in 2006; P<0.05), and partially hydrogenated oils (56% in 2007 vs 49% in 2006; P<0.05). Knowledge about food sources of different fats remained low. On an unaided basis, 21% could name three food sources of trans fats in 2007, up from 17% in 2006 (P<0.05). Knowledge of food sources of saturated fat remained unchanged at 30% in 2007. Significantly more respondents in 2007 reported behavioral changes related to trans fat information, such as buying food products because they show “zero trans fat” on labels or packages (37% in 2007 vs. 32% in 2006; P<0.05). Between 2006 and 2007, consumer awareness about trans fats increased and attained awareness levels similar to saturated fats. The increased awareness is associated with improved self-reported behaviors in grocery shopping. Nonetheless, overall knowledge, especially regarding food sources of saturated and trans fats, remains relatively low, underscoring the need for heightened consumer education activities. The positive change in consumer awareness about trans fats is likely attributable to the wide range of messages available to them, including the AHA “Face the Fats” national consumer education campaign. 相似文献
82.
Background
Traumatic perforation of the distal oesophagus due to blunt trauma is a very rare condition and is still associated with a significant morbidity and mortality. This is further exacerbated by delayed diagnosis and management as symptoms and signs are often masked by or ascribed to more common blunt thoracic injuries. 相似文献83.
Israel Liberzon Stephan F Taylor K Luan Phan Jennifer C Britton Lorraine M Fig Joshua A Bueller Robert A Koeppe Jon-Kar Zubieta 《Neuropsychopharmacology》2007,61(9):1030-1038
BACKGROUND: Functional neuroimaging studies have detected abnormal limbic and paralimbic activation to emotional probes in posttraumatic stress disorder (PTSD), but few studies have examined neurochemical mechanisms that underlie functional alterations in regional cerebral blood flow. The mu-opioid neurotransmitter system, implicated in responses to stress and suppression of pain, is distributed in and is thought to regulate the function of brain regions that are implicated in affective processing. METHODS: Here we examined the micro-opioid system with positron emission tomography and the micro-opioid receptor-selective radiotracer [11C] carfentanil in 16 male patients with PTSD and two non-PTSD male control groups, with (n = 14) and without combat exposure (n = 15). Differences in micro-opioid receptor binding potential (BP2) were detected within discrete limbic and paralimbic regions. RESULTS: Relative to healthy controls, both trauma-exposed groups had lower micro-opioid receptor BP2 in extended amygdala, nucleus accumbens, and dorsal frontal and insular cortex but had higher BP2 in the orbitofrontal cortex. PTSD patients exhibited reduced BP2 in anterior cingulate cortex compared with both control groups. Micro-opioid receptor BP2 in combat-exposed subjects without PTSD was lower in the amygdala but higher in the orbitofrontal cortex compared with both PTSD patients and healthy controls. CONCLUSIONS: These findings differentiate the general response of the micro-opioid system to trauma from more specific changes associated with PTSD. 相似文献
84.
85.
Christopher D Gardner James L Zehnder Alison J Rigby Joel R Nicholus John W Farquhar 《Blood coagulation & fibrinolysis》2007,18(8):787-793
Several case reports have implicated Ginkgo biloba in clinically adverse bleeding disorders. Ginkgo biloba has been reported to increase pain-free walking distance among patients with peripheral artery disease (PAD). Standard PAD therapy includes 325 mg/day aspirin. The objective of this study was to examine potential adverse effects of concomitant aspirin and Ginkgo biloba on platelet function. Ginkgo biloba (EGb 761, 300 mg/day) was compared with placebo for effects on measures of platelet aggregation among adults consuming 325 mg/day aspirin in a randomized, double-blind, placebo-controlled, parallel design trial of 4-week duration. Participants were adults, age 69 +/- 10 years, with PAD or risk factors for cardiovascular disease. Outcome measures included platelet function analysis (PFA-100 analyzer) using ADP as an agonist (n = 26 placebo; n = 29 ginkgo), and platelet aggregation using ADP, epinephrine, collagen and ristocetin as agonists (n = 21 placebo; n = 23 ginkgo). Participants kept daily logs of bleeding or bruising episodes. There were no clinically or statistically significant differences between treatment groups for any agonists, for either PFA-100 analysis or platelet aggregation. Reports of bleeding or bruising were infrequent and similar for both study groups. In conclusion, in older adults with PAD or cardiovascular disease risk, a relatively high dose of Ginkgo biloba combined with 325 mg/day daily aspirin did not have a clinically or statistically detectable impact on indices of coagulation examined over 4 weeks, compared with the effect of aspirin alone. No adverse bleeding events were observed, although the trial was limited to a small sample size. 相似文献
86.
87.
88.
Robert L Fortune 《European journal of cardio-thoracic surgery》2004,26(5):1056-7; author reply 1057-8
89.
90.
Maninder S Kalkat Ishtiaq Rahman Kostas Kotidis Ben Davies Robert S Bonser 《European journal of cardio-thoracic surgery》2007,32(2):250-254
BACKGROUND: In Marfan's syndrome, there is a paucity of data regarding intervention criteria for surgery of the dissected thoraco-abdominal aorta. METHODS: A retrospective analysis of 22 Marfan's patients with distal aortic dissection managed between September 1999 and April 2006 was performed. Serial diameters and linear expansion rates were calculated from imaging studies and the outcome of intervention was analysed. RESULTS: There were 14/22 male patients (median age 38 years), and 18 had prior aortic surgery. Surgery was recommended in 20 patients and undertaken in 19 (1 died prior to operation). Of the operated patients, 2 presented with rupture, 2 with airway obstruction, 1 with intermittent paraplegia and 14 underwent planned surgery for increased expansion rate or pain. All patients had residual type A or chronic type B dissection. The median aortic dimension at surgery was 6.7 cm (interquartile range (IQR) 5.5-8.2). The preoperative mean expansion rate increased from 0.5 cm/year to 1.7 cm/year (p<0.001), prior to operation. Fifteen patients underwent Crawford Extent II, two underwent Extent I and two underwent Extent III repair. Profound hypothermia and CSF drainage was used in 16 and 18 patients, respectively. There was no early mortality, paraplegia or renal failure. At a median postoperative follow-up of 56 months (range 6-86), the survival of the operated cohort was 90%. CONCLUSIONS: Thoraco-abdominal aortic aneurysm repair in Marfan's syndrome can be performed with good outcomes. Intervention should be based on size or accelerated expansion. Any role of endovascular management needs careful consideration. 相似文献